Drug Type Autologous CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism BAFF modulators(B-cell-activating factor/B lymphocyte stimulator modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diffuse Large B-Cell Lymphoma | Phase 1 | China | 30 May 2024 | |
| Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia | Phase 1 | China | 30 May 2024 | |
| Neuromyelitis Optica | Phase 1 | China | 15 Apr 2024 | |
| Scleroderma, Systemic | Phase 1 | China | 15 Apr 2024 | |
| Systemic Lupus Erythematosus | Phase 1 | China | 15 Apr 2024 |





